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Abstract
Background: Malaria continues to claim one to two million lives a year, mainly those of children
in sub-Saharan Africa. Reduction in mortality depends, in part, on improving the quality of hospital
care, the training of healthcare workers and improvements in public health. This study examined
the prognostic indicators of severe falciparum malaria in Gabonese children.
Methods: An observational study examining the clinical presentations and laboratory features of
severe malaria was conducted at the Centre Hospitalier de Libreville, Gabon over two years.
Febrile children aged from 0 to 10 years with Plasmodium falciparum infection and one or more
features of severe malaria were enrolled.
Results: Most children presenting with severe falciparum malaria were less than 5 years (92.3% of
583 cases). Anaemia was the most frequent feature of severe malaria (67.8% of cases), followed by
respiratory distress (31%), cerebral malaria (24%) hyperlactataemia (16%) and then hypoglycaemia
(10%). Anaemia was more common in children under 18 months old, while cerebral malaria usually
occurred in those over 18 months. The overall case fatality rate was 9%. The prognostic indicators
with the highest case fatality rates were coma/seizures, hyperlactataemia and hypoglycaemia, and
the highest case fatality rate was in children with all three of these features.
Conclusions: Prompt and appropriate, classification and treatment of malaria helps identify the
most severely ill children and aids early and appropriate management of the severely ill child.
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Each year 500 million infections and up to 2.7 millions
deaths are attributable to malaria [1], about 90% of these
deaths occur in children in sub-Saharan Africa [2]. Eighty
percent of the deaths occur during the first 24 hours fol-
lowing admission [3-5]. Despite a better understanding of
pathophysiology and management of malaria, childhood
mortality remains unacceptably high [6]. The acquisition
of malaria immunity is closely linked to the level of trans-
mission and severe Plasmodium falciparum infection is very
rare after the age of 5 years in highly endemic areas. Pres-
entations of severe malaria are different at different ages
and in areas with different levels of transmission. In
Gabon, a country of about 1.2 million people, malaria is
the main cause of neurological, haematological and infec-
tious emergencies at the Centre Hospitalier de Libreville
(CHL), the country's tertiary referral centre [7]. Malaria
transmission is hyperendemic and perennial with an
entomological inoculation rate of 50 per person-year [8].
Previous studies in Africa have shown three frequent pres-
entations of severe falciparum malaria: cerebral malaria,
metabolic malaria (hyperlactaemia, acidosis or respira-
tory distress) and severe anaemia [3,5,9]. The case fatality
rate of severe anaemia, however, is low and in some stud-
ies it is not an independent predictor of death [9,10]. In
Africa, malaria mortality remains high for a number of
reasons including limited access to healthcare and
increased drug resistance [6]. Better classification of severe
malaria could aid clinicians caring for children with severe
malaria to avoid diagnostic delays, identify the children
most likely to die and thus improve management by tar-
geting resources to the sickest children. This prospective
observational study was designed to determine the clini-
cal and laboratory features that identify those children
most severely ill with malaria.
Methods
This study was carried out in the CHL between 1st August
2000 and 31st July 2002. The CHL is the largest public
hospital in the country, situated in Libreville, the capital
city (pop. 500,000). Services at the CHL include an Emer-
gency Department (20 beds), a Paediatrics Unit (80 beds)
and an Intensive Care Unit (12 beds). Ethical permission
for the study was granted by the Gabonese Ministry of
Health.
Febrile children were referred the study team and seen on
admission by a Malaria Clinical Research Unit (MCRU)
clinician, summary data were recorded on a pro-forma
sheet. A blood sample (2 ml) was drawn (anti-coagulated
with EDTA) for quantitative examination of a blood film
for malarial parasites using the Lambaréné method [11],
measurement of haemoglobin concentration, white cell
count, platelet count (STKS, Coulter Corporation) and
blood lactate and glucose concentrations. Within 15 min-
utes of blood sampling, blood lactate and glucose concen-
trations were measured using Accusport™ hand held
analyser (Bohringer, Manheim, Inc., Germany) and One-
touch Analyzer (LifeScan, Inc., USA) [11]. Blood films
were defined as negative if there were no asexual forms of
P. falciparum in 100 high power fields of a thick film. The
schematic process of the inclusion is shown in Figure 1.
Febrile children (or those with history of fever in the last
48 hours) were considered for inclusion in the study if
they were: aged 0 to 10 years of age (inclusive), had
malaria (> 2 asexual forms of P. falciparum seen on blood
film) and had one or more of the following features of
severity: [9,12,13]: Blantyre coma score (BCS) ≤ 2 defin-
ing cerebral malaria, repeated observed seizures (3 or
more observed in 24 hours), lactate concentration in
whole blood or capillary blood ≥ 5 mmol/L, glucose con-
centration in whole blood or capillary blood ≤ 2.2 mmol/
L, severe anaemia (haemoglobin concentration of < 5 g/
dL) and/or haematocrit concentration < 15%). Children
were excluded from the study if informed consent was not
obtained from a relative or if an alternative diagnosis was
made clinically or by investigation (such as cerebrospinal
fluid examination, chest radiography or blood culture).
Schematic process of the screening of febrile children in the Centre Hospitalier de Libreville, GabonFigu  1
Schematic process of the screening of febrile children in the 
Centre Hospitalier de Libreville, Gabon.
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more of these features [14]: abnormalities in respiratory
rate (according to the age), rhythm (Kussmaul's or
Cheyne-Stokes's breathing) and signs of distress such as
nasal flaring, intercostal or subcostal recession.
Management
All children enrolled were hospitalised and treated with
parenteral quinine (12.5 mg salt/kg/day, intravenous;
Quinimax*, Sanofi-Synthelabo, France) without a load-
ing dose, followed by oral quinine when tolerated. Pyrex-
ial children received paracetamol suppositories (60 mg/
kg/day, rectal; Efferalgan™, Bristol- UPSA, France). Sei-
zures were controlled with diazepam (0.3 mg/kg, iv or 0.5
mg/kg rectal; Valium™, Roche, France). Severe anaemia
was corrected by transfusion of packed red cells (15 ml/kg
over 4 hours) screened for blood borne infections.
Hypoglycaemia was treated with a slow intravenous injec-
tion of hypertonic glucose 40 %(Braun, Germany) at a
dose of 1 ml/kg. Nasal oxygen at 6 1/minute was given to
children with respiratory distress.
Follow up
An MCRU clinician performed a full physical examination
daily until discharge for each child. Laboratory assess-
ments including parasitaemia, blood glucose and lactate
were performed during hospitalization as necessary. The
outcome (survived, death) was recorded.
Statistical analysis
Statistical analysis was carried out with Epi info 6.04
(ENSP-Epiconcept- InVS, Corp.) and Stata Statistical Soft-
ware (version 7.0, Stata Corporation, College Station,
Texas, USA). Normality of data distribution was checked
using either Shapiro-Wilks or Kolmogrov -Smirnov test.
Normally distributed data were analysed by two-tailed
Student's T test and non-normally distributed data with
the Mann-Whitney U statistic. Proportions were com-
pared with χ2 tests with Yates' correction or Fisher's exact
test. ANOVA test were used for multiple comparisons of
variances, with Tukey's post hoc test. Assessments of prog-
nostic factors were conducted with logistic regression
model. A p value < 0.05 was considered as significant. Spe-
cific prevalence for each subgroup has been defined as the
ratio of the number of cases observed in this sub-group
over the population of this same sub-group. Hyperlacta-
taemia is usually defined as a blood lactate concentration
of ≥ 5 mmol/L. As the Accusport has been found to have
poor agreement with the gold standard YSI 2300 [11] or
YSI 1500 sport [15], a definition of hyperlactataemia as
Admission characteristics of the study population (All results are mean ± SD except those specifiedFigure 2
Admission characteristics of the study population (All results are mean ± SD except those specified.
Variables Severe malaria (n=583) Survived (n=524) Died (n=52)
Demographic
Age (months)
Male : Female
Height (cm)
Weight (kg)
25.5 ± 19.2
299/284
87.9 ± 63.9
10.8 ± 3.6
25.0 ± 18.2
274/250
88.1 ± 66.2
10.7 ± 3.3
31.0 ± 26.9
20/31
86.3 ± 21.9
11.9 ± 5.5
Clinical
Temperature (°C)
Pulse (per min)
Respiratory rate (per min)
Coma - BCS   2 (%)
Respiratory distress (%)
38.5 ± 2.5
143.9 ± 28.3
49.7 ± 21.7
24.5
31.0
38.6 ± 3.3
144.5 ± 27.5
49.2 ± 21.5
21.0
28.2
38.1 ± 1.4
137.0 ± 35.0
54.5 ± 23.2
60.8
62.7
Laboratory
Lactate (mmol/L)
Glucose (mmol/L)
Hemoglobin (g/dL)
Geo. mean parasitaemia/ L (IQR)
Platelets (/uL)
White blood cells (/uL)
6.2 ± 4.3
5.8 ± 2.7
5.0 ± 2.5
28,332 (8,800-113,597)
125,859 ± 7,9434
13,949 ± 8,773
5.8 ± 3.9
5.8 ± 2.6
4.9 ± 2.4
27,893 (8890-105943)
124,052 ± 76,792
13,532 ± 8,443
10.4 ± 6.0
5.2 ± 3.2
5.6 ± 2.9
33,297 (7,160-214,525)
144,429 ± 101,815
18,229 ± 10,831Page 3 of 8
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increase the specificity in the analysis.
Results
Demographic and clinical data
During the study period (1st August 2000-31st July 2002),
8,036 febrile children were screened for malaria at the
hospital. The data for 7,980 of these children were ana-
lysed: 4,368 male (54.5%) and 3,612 female (45.5%).
Seventy-five percent these were less than 5 years of age.
3,156 (39.3%) of the 8,036 febrile children screened in
the MCRU had a positive blood film for P. falciparum. A
lower prevalence of malaria was seen in children aged< 6
months (3.7%, n = 118, p < 0.001). Specific prevalence of
malaria rises after the 6 first months of life until it reaches
a maximum at 47 months (47.5%), after which it declines
again. Severe anaemia was most frequent in children less
than 24 months old with 68 % of the cases of severe
malarial anaemia occurring before this age. In contrast,
the highest specific prevalence of cerebral malaria was
found in children aged > 12 months. Sixty five percent of
cases of cerebral malaria occurred in children aged
between 12–48 months.
Characteristics of severe malaria
The admission clinical, laboratory and parasitological
characteristics of the 583 children with severe malaria are
shown in the Figure 2. Two hundred and ninety nine of
the severe malaria cases were male (51.3%) and 536
(92%) of the children with severe malaria were less than
5 years old. A history of vomiting, seizures and anti-malar-
ial treatment before admission were reported in 322
(55.2%), 267 (45.8%) and 315 (54%) of the children
with severe malaria respectively. Despite significant fluc-
tuations in rainfall, the number of malaria cases per
month was sustained during the study period, confirming
the perennial transmission of malaria in this region.
Severe anaemia was the commonest feature of severe
malaria present in 395 (67.8%,) of the children. Neuro-
logical presentations (either coma or repeated convul-
sions) were present in 228 (39.2%) of the children.
Respiratory distress occurred in 181 (31%) of the children
; hyperlactataemia in 73 (15.7%) and hypoglycaemia in
33 (6.2%) of the children with severe malaria. Hyperpar-
asitaemia (> = 20% of circulating infected red blood cells)
was relatively rare, occurring in only 24 (4.1%) of the chil-
dren with severe malaria.
Renal failure, acute pulmonary oedema and spontaneous
bleeding are uncommon complications of childhood
malaria [5,9,10] and were not seen in this study. Circula-
tory collapse was not found alone in this study and was
not considered in the statistical analysis. One hundred
and forty six (25%) children with severe malaria were afe-
brile on admission to hospital.
Case rate fatality
Figure 3 shows a Venn diagram summarizing clinical and
laboratory features of severe malaria and case fatality
rates.
Of 583 patients, 52 died (40% male), giving an overall
case fatality rate of 8.9%. Seven children were lost to fol-
low-up. Forty seven deaths (90%) occurred within the first
24 hours after admission.
Neurological sequelae were present in 27 (5 %) of the 531
survivors. The case fatality rate was significantly higher in
females than males (10.9% vs.6.9%, p = 0.006). Children
who died were older than those who survived (mean (SD)
= 35.4 (41.9) vs. 25.0 (18.2) months, p = 0.0009).
Of the 52 deaths in the course of the study, 32 (61.5%)
presented with cerebral malaria, 32 (61.5%) presented
Venn diagram of features of 463 cases with a complete data-set of clinical measuresFigure 3
Venn diagram of features of 463 cases with a complete data-
set of clinical measures. Case fatality rates shown in brackets.
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measurements) had hyperlactataemia.
Thirty (60%) of the children who died presented with
convulsions, and 13 (25%) with hypoglycaemia. Twenty
four (46.2%) of those who died had severe anaemia. Mor-
talities in each sub-group demonstrated that hyperparasi-
taemia (1 death in 24, 4%) and severe anaemia (24 deaths
in 395, i.e. 6%) had a better prognosis than cerebral
malaria (32 deaths in 142, i.e. 22.5%) and hypoglycaemia
(15 deaths in 60, i.e. 25%). Thirty-two (17.7%) of the 181
patients with RD died, as did 30 (11%) of the 264 patients
with convulsions and 20 (27.4 %) of the 73 patients with
hyperlactataemia.
A multiple logistic regression model identified coma (OR
= 3.6, 95% CI = 1.8–7.1, p < 0.001), hyperlactataemia
(OR = 6.98, 95% CI = 3.5–13.8, p = 0.0001), respiratory
distress (OR = 2.0, 95% CI = 1.0–3.9, p = 0.033) and
hypoglycaemia (OR = 4.0, 95% CI = 1.7–9.4, p = 0.001)
as independent predictors of a fatal outcome. Severe anae-
mia, hyperparasitaemia and thrombocytopaenia were not
shown to be predictors of death (Figure 4).
Discussion
Malaria remains a serious health problem in sub-Sahara
Africa. It was the most common reason for neurological
emergencies during 2001 at the CHL [7]. This study was
designed to describe the epidemiology, clinical and labo-
ratory presentations of severe falciparum malaria in child-
hood presenting to CHL, in order to improve the
diagnosis, classification and appropriate management of
malaria. It is not possible to exclude absolutely all chil-
dren with alternative diagnoses on clinical examination
and simple investigation alone, which is a problem shared
by all other similar studies on severe malaria [3-
5,9,10,14,16-18]. The small numbers with alternative
diagnoses should not affect the conclusions of this or
other studies. Most cases (92%) of severe malaria were in
children less than 5 years old. Similar observations have
been made in another group of children hospitalized for
malaria in Gabon [19]. Elsewhere, severe malaria tends to
occur in older children [20]. Differences in the age of pres-
entation of severe malaria may be the result of lower back-
ground immunity or other undefined variables [21]. The
study confirms the stable and perennial transmission of
malaria in Gabon, which contrasts with reports from
other countries in West Africa where malaria transmission
is predominantly at the end of the long rainy season
[22,23].
Fever is a characteristic feature of P. falciparum infection,
but a sizeable proportion of these children (25%) with
severe malaria were afebrile on admission as observed
elsewhere [23]. Self-medication with antipyretic or anti-
malarial agents was common (about 50% of the children)
and may contribute to this finding. There are obvious
implications for the diagnosis of malaria, which may be
underestimated using clinical criteria alone.
Severe anaemia was the most frequent feature of severity
in this study, but was associated with decreased mortality.
Prognostic indicators at the time of admissionFigure 4
Prognostic indicators at the time of admission. OR – odds ratio, SD – standard deviation.
Outcome Prevalence
(n, %)
OR SD P [95% Conf.
Interval]
Cerebral malaria [142, 24%] 3.61 1.24 0.000 1.83 7.10
Severe anaemia [395, 60%] 0.63 0.21 0.174 0.32 1.22
Hypoglycaemia [33, 6%] 4.00 1.74 0.001 1.70 9.41
Hyperlactataemia [73, 15%] 6.98 2.43 0.0001 3.52 13.82
Respiratory distress syndrome [181, 31%] 2.04 0.68 0.033 1.05 3.94Page 5 of 8
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a better outcome in children with severe anaemia [17].
These findings confirm that severe malaria anaemia has a
lower case fatality rate than other complications of severe
malaria, consistent with several other studies where severe
anaemia was not an independent predictor of in-hospital
mortality [9,10,18]. The case fatality rate of severe anae-
mia without other markers of severe malaria is 1 to 2%,
where blood transfusion is available [3,9,10,14,18] rais-
ing questions about the value of severe anaemia as a
defining feature of the syndrome of severe malaria.
Despite the increasing toll of HIV infection, and the con-
tinuing burden of diarrhoeal disease, malnutrition and
respiratory tract infections, malaria remains a major cause
of childhood death in endemic regions [1]. The overall
case fatality rate of severe malaria in the study was 8.9%
(52 deaths/583 cases), which is in keeping with studies
from other geographic areas, where case fatality rates
range between 8 and 40% [4,5,9,14,16,20,22,24,25].
Most of these deaths (90% in this study) occurred in the
first twenty-four hours of hospital admission, a finding
also in keeping with other studies [5].
The independent prognostic indicators in this study were
cerebral malaria, respiratory distress, hypoglycaemia and
hyperlactataemia. These observations are entirely
consistent with a large number of studies where the inde-
pendent predictors of a fatal outcome in malaria are
impaired consciousness and metabolic dysfunction (as
measured by hyperlactataemia, hypoglycaemia, acidosis
or respiratory distress) [3,5,9,10,14,16-18]. The metabolic
complications of malaria are complex and a number of
interrelated measures have been used in different studies.
Severe malaria is associated with a metabolic acidosis [16]
and hyperlactataemia [5]. Respiratory distress has been
associated with acidosis and hyperlactataemia in some
studies [26]. These features of metabolic malaria probably
all result from increased anaerobic metabolism due to tis-
sue hypoxia [27].
Estimates of the prevalence of hypoglycaemia have been
reported in Africa, ranging from 8% to 34% [28,29]. In
severe childhood malaria hypoglycaemia results from
impaired gluconeogenesis and increased tissue demand
for glucose [27,28] and quinine induced hyperinsulinae-
mia. Blood glucose concentrations should be monitored
in all children hospitalised for malaria especially those
who receive quinine.
The definition of hyperlactataemia used in this study was
a blood lactate concentration higher than the conven-
tional cut-off (≥ 5 mmol/L). This was necessary because of
the limitations of the analyser used, but probably means
that the frequency of true hyperlactataemia was underesti-
mated. The Accusport™ analyser used has been shown to
have poor agreement with "gold standard" machines
[11,15,30].
Hyperlactataemia is a frequent and serious complication
of severe malaria in childhood [5,9,10], which may be
due microcirculatory sequestration of parasitized erythro-
cytes resulting in increased production of lactate by anaer-
obic glycolysis [31]. A recent study showed a correlation
between hyperlactataemia and high plasma glutamine
levels in severe malaria. This correlation may reflect
impaired gluconeogenesis [31]. Lactate disposal is pro-
portional to blood lactate concentration and can be
increased by dichloroacetate [27,32]. Lactic acidosis, as
confirmed in this study, is an established strong predictor
of a fatal outcome in falciparum malaria in African chil-
dren [5,9,10] and may prove a target for further interven-
tional studies to improve survival. Respiratory distress was
present in 31% of these children. This is higher than the
frequency reported in other studies of severe malaria:
4.9% in Burkina [20], 6.4% in Togo [22] and 13.7% in
Kenya [14].
These differences may partly be explained by low inter-
observer agreement for this variable, geographical varia-
tions in disease pattern as well as differing definitions of
severe malaria. Results from many studies consistently
show that respiratory distress is a life-threatening syn-
drome in childhood malaria [14,33]. Respiratory distress
was significantly associated with both hyperlactataemia
and cerebral malaria in this study. The Blantyre coma
score has long been established in children as a good indi-
cator of cerebral dysfunction in malaria [3] and has ena-
bled better standardization of studies on cerebral malaria
in African children. The case-fatality rate associated with
cerebral malaria (22%) is similar to that in Gambian chil-
dren (27%) [4] but is higher than that observed for Ken-
yan (17%) [14] and Malawian children (15%) [3]. It has
been postulated that with the higher the level of malaria
transmission, immunity is acquired earlier, perhaps alter-
ing the presentation of severe malaria from predomi-
nantly a cerebral syndrome to that of severe anaemia
[34,35].
The clinical and laboratory presentations of severe
malaria are described in a hospitalized population of chil-
dren in Gabon. The severe cases are likely to be only the
"tip of the iceberg", many children living far from health
care units may die whilst travelling to the nearest hospital.
Most deaths from malaria occurred in the first 24 hours of
admission, which highlights the need for early recogni-
tion of the most severely ill children. Early diagnosis and
classification of severe malaria would allow appropriate
management, including basic adjunctive therapy such as
to prevent hypoglycaemia, and better use of scarce health-Page 6 of 8
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tribute to a reduction in the intractably high mortality due
to the disease.
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